Adding-On a Brief Skill-Based HIV Prevention Psychoeducation to Needle and Syringe Programs: A Randomized Controlled Trial

Authors Information
Article Notes and Dates
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 372(9651): 1733-45[DOI][PubMed]
  • 2. Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HP, Care among ID, et al. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004; 18(17): 2295-303[PubMed]
  • 3. Rafiey H, Narenjiha H, Shirinbayan P, Noori R, Javadipour M, Roshanpajouh M, et al. Needle and syringe sharing among Iranian drug injectors. Harm Reduct J. 2009; 6: 21[DOI][PubMed]
  • 4. Islamic Republic of Iran AIDS Progress Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS. 2015;
  • 5. Jahani MR, Kheirandish P, Hosseini M, Shirzad H, Seyedalinaghi SA, Karami N, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS. 2009; 23(4): 538-40[DOI][PubMed]
  • 6. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1): 19-22[PubMed]
  • 7. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012; 23(4): 271-8[DOI][PubMed]
  • 8. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010; 14(1)-33[DOI][PubMed]
  • 9. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005; 19(7): 709-16[PubMed]
  • 10. Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, et al. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy. 2010; 21(6): 493-500[DOI][PubMed]
  • 11. Ramezani Tehrani F, Malek-Afzali H. Knowledge, attitudes and practices concerning HIV/AIDS among Iranian at-risk sub-populations. East Mediterr Health J. 2008; 14(1): 142-56[PubMed]
  • 12. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. 2008;
  • 13. Kimber J, Palmateer N, Hutchinson S, Hickman M, Goldberg D, Rhodes T. Harm reduction among injecting drug users - evidence of effectiveness. In: EMCDDA. Harm Reduction: Evidence, Impact and Challenges. 2010;
  • 14. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010; 105(5): 844-59[DOI][PubMed]
  • 15. Drug Misuse: Psychosocial Interventions, Full guideline. Leicester and London. 2008;
  • 16. Naserbakht M, Noroozi A, Hajebi A. A Multi-Center Randomized Controlled Trial of Adding Brief Skill-Based Psychoeducation to Primary Needle and Syringe Programs to prevent Human Immunodeficiency Virus: Study Protocol. Iran J Psychiatry. 2014; 9(3): 175-80[PubMed]
  • 17. Akhgari M, Jokar F, Bahmanabadi L, Aleagha A. Street-level heroin seizures in Iran: a survey of components. J Substance Use. 2012; 17(4): 348-55
  • 18. Bridge J. Route transition interventions: potential public health gains from reducing or preventing injecting. Int J Drug Policy. 2010; 21(2): 125-8[DOI][PubMed]
  • 19. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, Sharp Research Team . Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006; 31(2): 163-71[DOI][PubMed]
  • 20. Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010; (1)[DOI][PubMed]
  • 21. Des Jarlais DC, Friedman SR, Friedmann P, Wenston J, Sotheran JL, Choopanya K, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS. 1995; 9(6): 611-7[PubMed]

Iranian Journal of Psychiatry and Behavioral Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check